Portfolio & Asset Strategy
Identifying and prioritizing the assets most likely to create durable commercial value.
Core capabilities
Six disciplines. One integrated view.
Each circle in our mark is a capability. Together they cover what a science-driven company needs to move from the lab to a defensible market position.
Clinical & Evidence Strategy
Research programs that meet regulatory standards and differentiate brands scientifically.
Regulatory Navigation
Roadmaps and documentation frameworks that reduce approval risk and accelerate market access.
Commercialization & Launch
Translating scientific work into market entry strategy, product positioning and revenue.
Advisory & Stakeholder Engagement
Building credibility with investors, regulators and clinical communities.
M&A and Investment Diligence
Evaluating scientific and commercial assets for acquisition, licensing or investment decisions.
How we engage
Advice when you need perspective. Leadership when you need execution.
Engagements are shaped around the decision in front of you and the team you already have.
Model 01
Senior advisory
Focused counsel for leadership teams, boards and investors facing a defining scientific or commercial decision.
- Portfolio and asset prioritization
- Evidence and claims strategy review
- Scientific and commercial diligence
Model 02
Embedded strategic leadership
Hands-on leadership inside your organization to build the plan and carry it through to market.
- Clinical and regulatory program leadership
- Launch planning and positioning
- Investor, regulator and KOL engagement